Navigation Links
Calcium Plaque Build-up in the Arteries Leads to Coronary Heart,Disease in Multi-Ethnic Groups

BETHESDA, Md., March 26, 2007--Having a build-up of calcium plaque in the arteries means increased risk of heart attacks and death from heart disease in multiple ethnic groups, according to new findings from the Multi-Ethnic Study of Atherosclerosis (MESA) funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. Previous studies have shown that increased coronary artery calcium is linked to greater risk of heart disease events and deaths in Caucasians. This study shows that this is true in other ethnic groups — blacks, Hispanics and Chinese — even though the amount of calcium build-up in these populations is low relative to Caucasians.

MESA evaluated 6,814 men and women with no prior heart disease for coronary calcium using CT scanning, and followed them for an average of 3.5 years.

"Coronary Artery Calcium as a Predictor of Near-Term Coronary Heart Disease Events in Major American Ethnic Groups," will be presented on March 26, 2007, at 9 a.m. at the Annual Scientific Session of the American College of Cardiology, held in New Orleans.

Diane Bild, M.D., M.P.H., study co-author and acting deputy director of the NHLBIs Division of Prevention and Population Studies, is available for comment. To schedule interviews, contact the NHLBI Communications Office at 301-496-4236.

Link to more information on coronary plaque and heart disease risk: http://www.nhlbi.nih.gov/health/dci/Diseases/Atherosclerosis/Atherosclerosis_WhatIs.html

The National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on
'"/>




Page: 1 2

Related medicine technology :

1. Calcium Channel Blocker Adalat GITS Offer Additional Benefits
2. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
3. Evidence of Nanoparticles Found in Plaque-Filled Arteries
4. CSL Therapy That Mimics “Good” Cholesterol May Reduce Plaque Volume in Coronary Arteries
5. CSL Therapy That Mimics Good Cholesterol May Reduce Plaque Volume in Coronary Arteries
6. First Study To Show Positive Benefit On Atherosclerosis For People With Early Signs Of Diseased Arteries
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Use of Sequenoms MassARRAY System Leads to Significant Scientific Advances in Understanding Cancer, Diabetes and Drug-Resistant Malaria
9. New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
Post Your Comments:
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /...ical company developing novel, proprietary,antibod...autoimmune,diseases, will host a webcast and confe...at 10:00 a.m. Eastern Time (4:00 p.m. Central Euro...ere published in the Journal,SCIENCE on August 15,...
(Date:8/14/2008)... PRINCETON, N.J., Aug. 14 /PRNewswire-FirstCall/...stage pharmaceutical company committed to,discover... treat viral,infections, reported unaudited financ...e 30, 2008. Pharmasset reported a net loss attribu...a loss per share of $0.69 for the,quarter ended Ju...
(Date:8/13/2008)... Provides risk managers with comprehensive overvi...posure and required coverage, CHICAGO, Aug. 13 /P...,technology arm of Aon Corporation (NYSE: AOC ) a...ce solutions, today announced it has launched a ne...he market-leading,browser-based risk management i...
(Date:8/13/2008)... Reduction of CRP with ISIS 353512 could provide ...renal and inflammatory diseases, CARLSBAD, Calif....ticals, Inc. (Nasdaq: ISIS ) announced today it h...tisense drug that inhibits the,production of C-rea...vated,in patients with a variety of diseases inclu...
Breaking Medicine Technology:Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 1WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 2Pharmos Corporation Announces Board and Management Changes 2440 1Pharmos Corporation Announces Board and Management Changes 2440 2Pharmos Corporation Announces Board and Management Changes 2440 3Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 1Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 1Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 2Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 4
...ss.--(BUSINESS WIRE)--Mar 14, 2007 - ArQule, Inc.,...ociety of,Clinical Oncology (ASCO) has accepted fo... 197 (A Phase 1 Dose Escalation Study of,ARQ 197, ...ients,with Metastatic Solid Tumors) at the 43rd AS...s presentation will describe findings,from a Phase...
...lough Announces Presentation Of Phase II Trial Res...t The 2007 Annual,Meeting Of The American College ...6, 2007 /PRNewswire-FirstCall/ --,Schering-Plough ...ase II trial of its novel oral thrombin receptor a...e 2007 annual Scientific Sessions,of the of Cardio...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2
(Date:8/20/2008)...usetts General Hospital (MGH) investigators have f...em cell appeared to protect gastrointestinal tissu...ir report published in the journal Stem Cells , t...icine report that mesenchymal stem cells (MSCs), k...allowed the regeneration of the gastrointestinal l...
(Date:8/20/2008)...NGTON, Aug. 20 /PRNewswire-USNewswire/ -- Yesterda... admitted to Huron Hospital after,suffering an ane...Ohio. At,the present time Rep. Tubbs Jones, condit...are available., Tuesday,s condition followed a fu...ming forum on electoral reform, scheduled for Sept...
(Date:8/20/2008)... Micro(R) PUMP and ELLEgirl.com Send Four Girls to...Summer, LOS ANGELES, Aug. 20 /PRNewswire/ -- Reti...eenage Web site ELLEgirl.com to send four contest,...Camp in Santa Monica,California. With the new sch...mpower girls to become successful women by helping...
(Date:8/20/2008)...IEGO, Aug. 20 /PRNewswire/ --You,re late for work,...r car won,t start. How do you deal with,the rising...ash out in,frustration, how you deal with anger af...r children and even your career., As hard as we m...push,our buttons. While feeling anger isn,t a bad ...
Breaking Medicine News(10 mins):Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:Taming Your Temper: Learning to Turn Down the Heat 2
...oLipo(TM) laser module received clearance from the...ted lipolysis, and its BBL(TM) broadband pulsed li...les. ProLipo represents the latest technological ...ber-delivered laser energy to target fatty tissue....
... food for its 2.3 million soldiers, with the milit... recent spate of health scandals, state media rep...e or substandard food products and eliminating the... eating from the same plate, according to an annou...
...r a day, the Australian police finally announced t... in southern India, was being charged with provid...em a mobile phone SIM card. His cousin Sabeel Ahm... in Runcorn, southeast of Liverpool, has been accu...
... registry of pregnancies and abortions to stem sel... according to a report. India has only 927 femal...ldwide average of 1,050 females -- mainly due to s...e country where many people prefer to have male ch...
Other Medicine News:Health News:Sciton Receives FDA Clearance for Lipolysis and Wrinkle Treatment 2Health News:Three Doctors Charged So Far in the UK Bombing Case 2Health News:Three Doctors Charged So Far in the UK Bombing Case 3Health News:Three Doctors Charged So Far in the UK Bombing Case 4Health News:India to Monitor Pregnancies to Check Girl Foeticide: Report 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: